StayCurrentMD · Clinical characteristics and target exploration via scRNA-seq and high-throughput drug screening of FOXO1 fusion positive rhabdomyosarcoma
Follow
Article1 min read·Published Nov 2025

Clinical characteristics and target exploration via scRNA-seq and high-throughput drug screening of FOXO1 fusion positive rhabdomyosarcoma

link.springer.com shows its articles on its own site.

Read the article on link.springer.com ↗

Article · Nov 2025 · 1 min read

About this article

Purpose Method Results Conclusion

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →